News

October 29, 2019 - REGELTEC CHOOSES COLOMBIA AND BIOACCESS™ FOR THE FIRST-IN-HUMAN CLINICAL TRIAL OF ITS HYDRAFIL SYSTEM
Picture
​Dec. 13, 2018 - ReGelTec Team at UPenn New Bolton Center for Preclinical Testing Day
Dec. 18, 2018- ReGelTec completes $2 Million Series Seed Funding Round​

Location
323 W CAMDEN STREET
SUITE 600
BALTIMORE, MD 21201
PHONE: 443-451-3915
​FAX: 443-451-3959​